Carpatem Softgel

About Carpatem® Softgel is a brand of Artemether Lumefantrine with a composition of 20mg Artemether and 120 mg Lumefantrine. It is a prescription medication used in the treatment of uncomplicated drug resistant malaria caused by P. falciparum, P. malariae. Carpatem® is a registered trademark of Carpa Healthcare limited. Administration Its available in tablet form and […]

Carpatem Plus Softgel

Carpatem Plus® is a brand of Artemether Lumefantrine with a composition of 20mg Artemether and 120 mg Lumefantrine. It is a prescription medication used in the treatment of uncomplicated drug resistant malaria caused by P. falciparum, P. malariae.

Rilshield

Rilshield® is a brand of Rilpivirine, a high potency second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV/AIDS. It is recommended for patients with a viral load of 100,000 copies/mL or less at the beginning of therapy.

Tenoveil

About Tenovail® is a brand of Tenofovir alafenamide fumarate (TAF), an antiviral medication used in the treatment of HIV/AIDS and Hepatitis B virus (HBV) infections. Tenovail® is known for its greater antiviral activity and distribution into lymphoid tissues. It is approved by FDA in the treatment of HIV-1 and is often prescribed in combination with […]

Carpatem

About Carpatem® is a brand of Artemether Lumefantrine with a composition of 20mg Artemether and 120 mg Lumefantrine. It is a prescription medication used in the treatment of uncomplicated drug resistant malaria caused by P. falciparum, P. malariae. Carpatem® is a registered trademark of Carpa Healthcare limited. Administration Its available in tablet form and administered […]

Carpatem Plus

Carpatem Plus® is a brand of Artemether Lumefantrine with a composition of 20mg Artemether and 120 mg Lumefantrine. It is a prescription medication used in the treatment of uncomplicated drug resistant malaria caused by P. falciparum, P. malariae.

Glucentra

Glucentra® is a brand of Metformin Hydrochloride and Glibenclamide Capsules with a combination of 250mg Metformin Hydrochloride and 1.25mg Glibenclamide. It is a hypogycemic agent used in the treatment of type 2 diabetes mellitus in adults as replacement for previous combination therapy with metformin and glibenclamide in patients whose glycaemia is stable and well-controlled.